文 献Ishida K, et al. High-sensitivity immunoassay with surface plasmon field-enhanced fluorescence spectroscopy using a plastic sensor chip: application to quantitative analysis of total prostate-specific antigen and GalNAcβ1-4GlcNAc-linked prostate-specific antigen for prostate cancer diagnosis. Anal Chem 2015; 87: 1797-803.7）Ohkuma R, Yada E, Ishikawa S, Komura D, Kubota Y, Hamada K, et al. High levels of human epididymis protein 4 mRNA and protein expression are correlated with chemoresistance and poor prognosis in pancreatic cancer. Int J Oncol 2021; 58: 57-69.8）Ohkuma R, Yada E, Ishikawa S, Komura D, Kubota Y, Hamada K, et al. and Wada S. High expression levels of polymeric immunoglobulin receptor are correlated with chemoresistance and poor prognosis in pancreatic cancer. Oncol Rep 2020; 44: 252-62.9）Ohkuma R, Yada E, Ishikawa S, Komura D, Ishizaki H, Komura D, et al. and Wada S. High expression of olfactomedin-4 is correlated with chemoresistance and poor prognosis in pancreatic cancer. PLoS One 2020; 15: e0226707.1081）Hodi FS, O'Day SJ, McDermott DF, Weber RW, Sosman JA, Haanen JB, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 2010; 363: 711-23.2）Topalian SL, Hodi FS, Brahmer JR, Gettinger SN, Smith DC, McDermott DF, et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med 2012; 366: 2443-54.3）Park JH, Rivière I, Gonen M, Wang X, Sénéchal B, Curran KJ, et al. Long-term follow-up of CD19 CAR therapy in acute lymphoblastic leukemia. N Engl J Med 2018; 378: 449-59.4）Chong EA, Ruella M, Schuster SJ. Five-year outcomes for refractory B-cell lymphomas with CAR T-cell therapy. N Engl J Med 2021; 384: 673-4.5）Morgan RA, Yang JC, Kitano M, Dudley ME, Laurencot CM, Rosenberg SA. Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2. Mol Ther 2010; 18: 843-51. 6）Kaya T, Kaneko T, Kojima S, Nakamura Y, Ide Y,
元のページ ../index.html#122